Montirelin

Montirelin

SCHEMBL3098148

CC1SCC(C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N2CCC[C@H]2C(N)=O)NC1=O

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TRHR P34981 6/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Montirelin SCHEMBL4955895 1.00 TRHR (0.55) TRHR
Montirelin SCHEMBL7354006 1.00 TRHR (0.55) TRHR
Montirelin SCHEMBL7311976 1.00 TRHR (0.55) TRHR
Montirelin SCHEMBL29405744 1.00 TRHR (0.55) TRHR
Montirelin SCHEMBL3095581 0.99 TRHR (0.54) TRHR
Montirelin SCHEMBL8498903 0.96 TRHR (0.52) TRHR
SCHEMBL7318759 0.91 TRHR (0.54) TRHR
SCHEMBL14028667 0.90 TRHR (0.43) TRHR
SCHEMBL7310894 0.89 TRHR (0.52) TRHR
SCHEMBL8257280 0.89 TRHR (0.42) TRHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0866711-B1 MONTIRELIN FOR INHIBITING SLEEP APNEA GRUENENTHAL GMBH (DE) 2006-07-26 — — EP claimed
EP-0862429-A4 METHOD OF ADJUSTING THE CIRCADIAN RHYTHM OF A MAMMAL GRUENENTHAL GMBH (DE) 2003-05-28 — — EP claimed
EP-0866711-A4 METHOD OF INHIBITING SLEEP APNEA GRUENENTHAL GMBH (DE) 2003-04-16 — — EP claimed
US-5968932-A ADMINISTERING 6-METHYL-5-OXO-3-THIOMORPHOLINYLCARBONYL-L-HISTIDYL-L-PROLINAM IDE GRUENENTHAL GMBH (DE) 1999-10-19 — — US claimed
US-5932541-A 6-METHYL-5-OXO-3-THIOMORPHOLINYLCARBONYL-L-HISTIDYL-L-PROLINAM IDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF GRUENENTHAL GMBH (DE) 1999-08-03 — — US claimed
EP-0866711-A1 METHOD OF INHIBITING SLEEP APNEA Grünenthal GmbH (DE) 1998-09-30 — — EP claimed
EP-0862429-A1 METHOD OF ADJUSTING THE CIRCADIAN RHYTHM OF A MAMMAL Grünenthal GmbH (DE) 1998-09-09 — — EP claimed
WO-1997015309-A1 METHOD OF INHIBITING SLEEP APNEA GRUENENTHAL, GMBH (DE) 1997-05-01 — — WO claimed
WO-1997015301-A1 METHOD OF ADJUSTING THE CIRCADIAN RHYTHM OF A MAMMAL GRUENENTHAL GMBH (DE) 1997-05-01 — — WO claimed
EP-0185210-B1 USE OF DIPEPTIDE DERIVATIVES FOR THE PREPARATION OF MEDICAMENTS FOR THE TREATMENT OF SUFFERERS FROM AMYOTROPHIC LATERAL SCLEROSIS Grünenthal GmbH (DE) 1991-06-12 — — EP claimed
EP-0188810-B1 USE OF DIPEPTIDE DERIVATIVES FOR THE PREVENTION OR TREATMENT OF POST-TRAUMATIC SPINAL AND/OR CEREBRAL NERVE DISORDERS Grünenthal GmbH (DE) 1990-10-31 — — EP claimed
US-4956364-A 6-ALKYL-5-OXO-3-THIOMORPHOLINYLCARBONYLHISTIDYLPROLINAMIDE NIPPON SHINYAKU CO., LTD. (JP) 1990-09-11 — — US claimed
US-4906614-A Method of treating posttraumatic nervous injuries with dipeptide derivatives GRUENENTHAL GMBH (DE) 1990-03-06 — — US claimed
US-4877784-A ANTIEPILEPTIC AGENTS NIPPON SHINYAKU CO., LTD. (JP) 1989-10-31 — — US claimed
US-4788179-A Method of treating amyotrophic lateral sclerosis with dipeptide derivatives and pharmaceutical compositions for use therein GRUENENTHAL GMBH (DE) 1988-11-29 — — US claimed
EP-0188810-A2 Use of dipeptide derivatives for the prevention or treatment of post-traumatic spinal and/or cerebral nerve disorders Grünenthal GmbH (DE) 1986-07-30 — — EP claimed
EP-0185210-A2 Use of dipeptide derivatives for the preparation of medicaments for the treatment of sufferers from amyotrophic lateral sclerosis Grünenthal GmbH (DE) 1986-06-25 — — EP claimed
JP-63316724-A — — None — — JP disclosed
US-4788179-A Method of treating amyotrophic lateral sclerosis with dipeptide derivatives and pharmaceutical compositions for use therein GRUENENTHAL GMBH (DE) 1988-11-29 — — US disclosed
EP-0185210-A2 Use of dipeptide derivatives for the preparation of medicaments for the treatment of sufferers from amyotrophic lateral sclerosis Grünenthal GmbH (DE) 1986-06-25 — — EP disclosed
Send feedback